Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, et al. A Phase 2 Trial of Selumetinib in Children with Recurrent Optic Pathway and Hypothalamic Low-Grade Glioma without NF1: A Pediatric Brain Tumor Consortium Study. Neuro Oncol 2021 Feb 25. pii: 6149924. doi: 10.1093.
PMID: 33631016